INDEPENDENT NEWS

Pharmac To Reconsider Herceptin Funding

Published: Thu 3 Apr 2008 02:51 PM
Media Release
03 April 2008
Pharmac To Reconsider Herceptin Funding
The eight breast cancer patients who took their case to the High Court seeking the overturning of Pharmac’s funding decisions for the cancer drug Herceptin can take some comfort from the High Court decision that Pharmac must reconsider and consult over its decision not to fund 12 months of Herceptin for women with early breast cancer, says New Zealand First health spokesperson Barbara Stewart.
“The ball is now back in Pharmac’s court.
“The court case will have been immensely stressful for all those involved and the review of this decision must not be dragged out any longer than is absolutely essential,” said Mrs Stewart.
ENDS

Next in New Zealand politics

Concerns Conveyed To China Over Cyber Activity
By: New Zealand Government
GDP Decline Reinforces Government’s Fiscal Plan
By: New Zealand Government
New Zealand Provides Further Humanitarian Support To Gaza And The West Bank
By: New Zealand Government
High Court Judge Appointed
By: New Zealand Government
Parliamentary Network Breached By The PRC
By: New Zealand Government
Tax Cuts Now Even More Irresponsible
By: New Zealand Labour Party
View as: DESKTOP | MOBILE © Scoop Media